|
|
| (121 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| − | {{tp|p=32302401|t=2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps |pdf=|usr=}}
| |
| | | | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32161092|t=2020. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32305884|t=2020. Epidemiology and clinical features of COVID-19: A review of current literature |pdf=|usr=}}
| + | |
| − | {{tp|p=32232339|t=2020. Forty years with coronaviruses |pdf=|usr=}}
| + | |
| − | {{tp|p=32139299|t=2020. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32307322|t=ä. Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis |pdf=|usr=}}
| |
| | | | |
| − | ----
| + | *'''[[Respiration mgmt]]''' |
| | | | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| − | *'''[[Structure of covid19]]'''
| |
| − | {{tp|p=32361692|t=2020. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure |pdf=|usr=}}
| |
| − | {{tp|p=32306836|t=2020. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Target binding and uptake]]''' | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=32344526|t=2020. COVID-19 and RAS: Unravelling an Unclear Relationship |pdf=|usr=}}
| + | |
| − | {{tp|p=32274964|t=2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| − | *'''[[Cytopathic effects]]'''
| |
| | | | |
| | + | |
| | + | |
| | + | *'''[[Structure of covid19]]''' |
| | + | |
| | + | |
| | + | *'''[[Target binding and uptake]]''' |
| | + | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32360285|t=ä. Type I IFN immunoprofiling in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32344056|t=ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination |pdf=|usr=}}
| |
| − | {{tp|p=32333914|t=ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia |pdf=|usr=}}
| |
| − | {{tp|p=32344321|t=2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32344320|t=ä. The clinical course and its correlated immune status in COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32353870|t=2020. The many faces of the anti-COVID immune response |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| − | {{tp|p=32334118|t=ä. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32360286|t=2020. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32311489|t=ä. Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| − | ----
| + | *'''[[Pathobiology]]''' |
| | + | |
| | + | |
| | + | *'''[[Disease Models]]''' |
| | + | |
| | + | |
| | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | + | |
| | + | |
| | | | |
| | | | |
| Zeile 58: |
Zeile 56: |
| | *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| | | | |
| − | *'''[[ARDS]]'''
| |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Hematology]]'''
| |
| | | | |
| − | *'''[[Microvascular]]'''
| |
| | | | |
| − | *'''[[Heart]]'''
| |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| − | {{tp|p=32251791|t=2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 |pdf=|usr=}}
| |
| − | {{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}}
| |
| − | {{tp|p=32332516|t=2020. Precaution and prevention of coronavirus disease 2019 infection in the eye |pdf=|usr=}}
| |
| − | {{tp|p=32353982|t=2020. The Ocular Surface and the Coronavirus Disease 2019: Does a Dual Ocular Route Exist?|pdf=|usr=}}
| |
| − | {{tp|p=32307298|t=ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis |pdf=|usr=}}
| |
| − | {{tp|p=32312628|t=ä. Guillain Barre syndrome associated with COVID-19 infection: A case report |pdf=|usr=}}
| |
| − | {{tp|p=32354690|t=ä. COVID 19 infection presenting as motor peripheral neuropathy |pdf=|usr=}}
| |
| − | {{tp|p=32327279|t=ä. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis |pdf=|usr=}}
| |
| − | {{tp|p=32334847|t=ä. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context |pdf=|usr=}}
| |
| − | {{tp|p=32165057|t=2020. Le nouveau Coronavirus Covid-19: quels risques ophtalmiques?|pdf=|usr=}}
| |
| | | | |
| − | *'''[[Dermatology]]''' | + | *'''[[Hematology]]''' |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32243269|t=2020. Gastrointestinal and liver manifestations in patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32361826|t=ä. COVID-19 and the endocrine system: exploring the unexplored |pdf=|usr=}}
| |
| − | {{tp|p=32300975|t=ä. COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency?|pdf=|usr=}}
| |
| − | {{tp|p=32345544|t=ä. The clinical manifestations and management of COVID-19-related liver injury |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Kidney, urology]]''' | + | *'''[[Heart]]''' |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Pathobiology]]'''} | + | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32357503|t=2020. COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!|pdf=|usr=}}
| + | |
| − | {{tp|p=32244779|t=2020. Master Regulator Analysis of the SARS-CoV-2/Human Interactome |pdf=|usr=}}
| + | |
| − | {{tp|p=32366599|t=2020. SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Disease Models]]''' | + | *'''[[Dermatology]]''' |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]''' | + | *'''[[Gastroenterology, hepatology]]''' |
| − | {{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
| + | |
| − | {{tp|p=32286019|t=2020. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives |pdf=|usr=}}
| + | |
| − | {{tp|p=32269100|t=2020. Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit |pdf=|usr=}}
| + | |
| − | {{tp|p=32350048|t=2020. Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories |pdf=|usr=}}
| + | |
| − | {{tp|p=32350047|t=2020. The Role of Antibody Testing for SARS-CoV-2: Is There One?|pdf=|usr=}}
| + | |
| − | {{tp|p=32341143|t=2020. Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32341142|t=2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32341141|t=2020. Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR |pdf=|usr=}}
| + | |
| − | {{tp|p=32332061|t=2020. Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32327448|t=2020. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32132196|t=2020. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32102856|t=2020. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32317257|t=2020. Saliva as a non-invasive specimen for detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32317256|t=2020. Validation of the Hologic s Aptima Unisex and Multitest Specimen collection kits used for Endocervical and Male Urethral Swab Specimen (Aptima Swab) for sample collection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32303565|t=2020. The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32303564|t=2020. Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32295896|t=2020. Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage |pdf=|usr=}}
| + | |
| − | {{tp|p=32277023|t=2020. A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32277022|t=2020. Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
| + | |
| − | {{tp|p=32361324|t=ä. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study |pdf=|usr=}}
| + | |
| − | {{tp|p=32302956|t=2020. Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT |pdf=|usr=}}
| + | |
| − | {{tp|p=32328218|t=ä. Salivary diagnostics in COVID-19: Future research implications |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[Kidney, urology]]''' |
| − | {{tp|p=32283052|t=ä. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32236303|t=2020. COVID-19 pneumonia: what is the role of imaging in diagnosis?|pdf=|usr=}}
| + | |
| − | {{tp|p=32321009|t=2020. COVID-19 pneumonia and the reversed halo sign |pdf=|usr=}}
| + | |
| − | {{tp|p=32294718|t=2020. Presentation of pulmonary infection on CT in COVID-19: initial experience in Brazil |pdf=|usr=}}
| + | |
| − | {{tp|p=32307320|t=ä. CT imaging of the COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32265095|t=ä. CT chest findings in coronavirus disease-19 (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32229062|t=ä. Necessitating repeated chest CT in COVID-19 pneumonia |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[The morbid survivor]]''' |
| | | | |
| | + | *'''[[Risk and special populations]]''' |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| − | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Respiration mgmt]]''' | + | *'''[[Case reports]]''' |
| − | {{tp|p=32339975|t=2020. Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience |pdf=|usr=}}
| + | |
| − | {{tp|p=32279018|t=ä. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| Zeile 156: |
Zeile 95: |
| | | | |
| | | | |
| − | *'''[[Risk and special populations]]'''
| |
| − | {{tp|p=32370269|t=2020. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?|pdf=|usr=}}
| |
| − | {{tp|p=32244852|t=2020. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19) |pdf=|usr=}}
| |
| − | {{tp|p=32335336|t=2020. SARS-CoV-2: Is it the newest spark in the TORCH?|pdf=|usr=}} ''Covid19 in neonates''
| |
| − | {{tp|p=32302955|t=2020. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32303756|t=ä. Impact of anti-tnf? antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases |pdf=|usr=}}
| |
| − | {{tp|p=32303430|t=ä. Asymptomatic case of Covid-19 in an infant with cystic fibrosis |pdf=|usr=}}
| |
| − | {{tp|p=32222956|t=ä. Prevalence and impact of diabetes among people infected with SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32299654|t=ä. The first case of COVID-19 infection in a 75-day-old infant in Jahrom City, south of Iran |pdf=|usr=}}
| |
| | | | |
| − |
| |
| − | *'''[[The morbid survivor]]'''
| |
| − | {{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − | *'''[[Case reports]]'''
| |
| − | {{tp|p=32269194|t=2020. Pneumonia Without Respiratory Symptoms |pdf=|usr=}}
| |
| − | {{tp|p=32361703|t=2020. Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report |pdf=|usr=}}
| |
| − | {{tp|p=32113824|t=ä. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32334915|t=ä. Letter to the Editor: Update on the followed-up CT exam of the first CoVID-19 pneumonia in Taiwan |pdf=|usr=}}
| |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32378815|t=2020. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center |pdf=|usr=}}
| |
| − | {{tp|p=32302954|t=2020. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu |pdf=|usr=}}
| |
| − | {{tp|p=32302953|t=2020. Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China |pdf=|usr=}}
| |
| − | {{tp|p=32298988|t=2020. Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32330817|t=2020. Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy |pdf=|usr=}}
| |
| − | {{tp|p=32249108|t=ä. COVID-19 pneumonia in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32317205|t=ä. Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32353761|t=2020. Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review |pdf=|usr=}}
| |
| − | {{tp|p=32305026|t=ä. Challenges of Convalescent Plasma Therapy on COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32314081|t=ä. Pharmacologic Therapy for COVID-19 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32289152|t=2020. COVID-19 and emerging viral infections: The case for interferon lambda |pdf=|usr=}}
| |
| − | {{tp|p=32302401|t=2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps |pdf=|usr=}}
| |
| − | {{tp|p=32359878|t=2020. Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | | + | *'''[[Other routes of infection]]''' |
| − | | + | |
| − | ----
| + | |
| | | | |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Other routes of infection]]'''
| |
| − | {{tp|p=32335340|t=ä. Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health |pdf=|usr=}}
| |
| − | {{tp|p=32278800|t=ä. Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?|pdf=|usr=}}
| |
| − | {{tp|p=32329026|t=ä. Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab |pdf=|usr=}}
| |
| | | | |
| | | | |
| − |
| |
| − | *'''[[Remission, recurrence and persistence]]'''
| |
| − | {{tp|p=32200109|t=2020. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge |pdf=|usr=}}
| |
| − | {{tp|p=32251796|t=ä. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?|pdf=|usr=}}
| |
| − | {{tp|p=32147538|t=2020. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report |pdf=|usr=}}
| |
| − | {{tp|p=32340768|t=ä. Risk of reactivation or reinfection of novel coronavirus (COVID-19) |pdf=|usr=}}
| |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=32278727|t=ä. Ethical Rationing of Personal Protective Equipment to Minimize Moral Residue During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32240303|t=ä. Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32353399|t=ä. Institution of a Novel Process for N95 Respirator Disinfection with Vaporized Hydrogen Peroxide in the setting of the COVID-19 Pandemic at a Large Academic Medical Center |pdf=|usr=}}
| |
| − | {{tp|p=32370924|t=ä. Personal Protective Equipment: Current Best Practices for Orthopaedic Teams |pdf=|usr=}}
| |
| − | {{tp|p=32354536|t=ä. Helmet Modification to PPE with 3D Printing During the COVID-19 Pandemic at Duke University Medical Center: A Novel Technique |pdf=|usr=}}
| |
| − | {{tp|p=32359911|t=ä. Plastic Bags as Personal Protective Equipment During the COVID-19 Pandemic: Between the Devil and the Deep Blue Sea |pdf=|usr=}}
| |
| − | {{tp|p=32278505|t=ä. Hygiene des mains et masques contre COVID-19: oser le degrade?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32367999|t=ä. Post COVID-19: Planning strategies to resume orthopaedic surgery ?challenges and considerations |pdf=|usr=}}
| |
| − | {{tp|p=32292256|t=2020. Working through the COVID-19 outbreak: Rapid review and recommendations for MSK and allied heath personnel |pdf=|usr=}}
| |
| − | {{tp|p=32312717|t=2020. Cytology in the time of coronavirus disease (covid-19): an Italian perspective |pdf=|usr=}}
| |
| − | {{tp|p=32237302|t=2020. A Viewpoint From Paris on the COVID-19 Pandemic: A Necessary Turn to Telepsychiatry |pdf=|usr=}}
| |
| − | {{tp|p=32303420|t=2020. Approaches to the management of patients in oral and maxillofacial surgery during COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32221526|t=ä. COVID-19 Outbreak and Inflammatory Bowel Disease Management: A Questionnaire Survey From Realistic Practice |pdf=|usr=}}
| |
| − | {{tp|p=32215548|t=ä. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?|pdf=|usr=}}
| |
| − | {{tp|p=32211765|t=ä. Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience |pdf=|usr=}}
| |
| − | {{tp|p=32162995|t=ä. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine |pdf=|usr=}}
| |
| − | {{tp|p=32296495|t=ä. The impact of the COVID-19 epidemic on the utilization of emergency dental services |pdf=|usr=}}
| |
| − | {{tp|p=32363005|t=ä. COVID-19 and its implications in the management of resource infrastructure |pdf=|usr=}}
| |
| − | {{tp|p=32337045|t=2020. Eating disorders in the time of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32243336|t=2020. ECT in a time of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32362732|t=ä. Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32362733|t=2020. Minimising aerosol generation during orthopaedic surgical procedures- Current practice to protect theatre staff during Covid-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32292257|t=2020. Annotation: The COVID-19 pandemic and clinical orthopaedic and trauma surgery |pdf=|usr=}}
| |
| − | {{tp|p=32243334|t=2020. Images in Clinical ECT: Immediate impact of COVID-19 on ECT Practice |pdf=|usr=}}
| |
| − | {{tp|p=32243335|t=2020. ECT during COVID-19: An Essential Medical Procedure ? Maintaining Service Viability and Accessibility |pdf=|usr=}}
| |
| − | {{tp|p=32150796|t=2020. How to train health personnel to protect themselves from SARS-CoV-2 (novel coronavirus) infection when caring for a patient or suspected case |pdf=|usr=}}
| |
| − | {{tp|p=32340737|t=ä. Can You Catch It? Lessons Learned and Modification of ED Triage Symptom- and Travel-Screening Strategy |pdf=|usr=}}
| |
| − | {{tp|p=32308272|t=2020. Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission |pdf=|usr=}}
| |
| − | {{tp|p=32335855|t=ä. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency |pdf=|usr=}}
| |
| − | {{tp|p=32360053|t=2020. Characteristics of Endodontic Emergencies during Coronavirus Disease 2019 Outbreak in Wuhan |pdf=|usr=}}
| |
| − | {{tp|p=32349775|t=2020. Cancer at the time of the COVID-19 hurricane |pdf=|usr=}}
| |
| − | {{tp|p=C7151404|t=ä. Take proactive measures for the pandemic COVID-19 infection in the dialysis facilities |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32259628|t=ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist |pdf=|usr=}}
| |
| − | {{tp|p=32208139|t=ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | {{tp|p=32360185|t=ä. Exercise and Fitness in the age of social distancing during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32078967|t=2020. Coronaphobia: Fear and the 2019-nCoV outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32333185|t=ä. Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32331246|t=2020. Questionnaire on Perception of Threat from COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32155302|t=2020. COVID?19: Emerging compassion, courage and resilience in the face of misinformation and adversity |pdf=|usr=}}
| |
| − | {{tp|p=32237301|t=2020. COVID-19 Diary From a Psychiatry Department in Italy |pdf=|usr=}}
| |
| − | {{tp|p=32237300|t=2020. COVID-19 From a Psychiatry Perspective: Meeting the Challenges |pdf=|usr=}}
| |
| − | {{tp|p=32271507|t=2020. Psychiatry s Niche Role in the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32271506|t=2020. "What Were You Before the War?" Repurposing Psychiatry During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32355392|t=ä. Purpose by design or disaster: Preserving a sense of purpose amid environmental uncertainty |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 292: |
Zeile 131: |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| | + | |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
| − | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 310: |
Zeile 145: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=32212099|t=ä. COVID-19 may transmit through aerosol |pdf=|usr=}}
| |
| − | {{tp|p=32373461|t=ä. An Environmental and Health Perspective for COVID-19 Outbreak: Meteorology and Air Quality Influence, Sewage Epidemiology Indicator, Hospitals Disinfection, Drug Therapies and Recommendations |pdf=|usr=}}
| |
| − | {{tp|p=32316979|t=2020. Baby pangolins on my plate: possible lessons to learn from the COVID-19 pandemic |pdf=|usr=}}
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32245833|t=2020. A pandemic in times of global tourism: superspreading and exportation of COVID-19 cases from a ski area in Austria |pdf=|usr=}}
| |
| − | {{tp|p=32305025|t=2020. Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32303920|t=ä. Coronavirus (COVID-19) in Haiti: A Call for Action |pdf=|usr=}}
| |
| − | {{tp|p=32363167|t=ä. Ramadan fasting during Covid-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32281555|t=2020. The Fast Territorial Expansion of COVID-19 in Spain |pdf=|usr=}}
| |
| − | {{tp|p=32048815|t=2020. Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019?nCoV |pdf=|usr=}}
| |
| − | {{ttp|p=32350383|t=ä. The COVID-19 pandemic: a moment for exposure science |pdf=|usr=}}
| |
| − | {{tp|p=32354499|t=2020. COVID-19, Pandemic, and Social Distancing |pdf=|usr=}}
| |
| − | {{tp|p=32222336|t=2020. Initial rapid and proactive response for the COVID-19 outbreak ? Taiwan s experience |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]''' | + | |
| | + | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
| + | |
| − | *[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
| + | |
| | | | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| |
| − |
| |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32343813|t=ä. Impact of the digital divide in the age of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32313877|t=ä. COVID-19 Epidemic and Enhancing China?s National Biosecurity System |pdf=|usr=}}
| + | |
| − | {{tp|p=32282413|t=ä. What?s Important: What Is Our Role in the COVID-19 Pandemic?|pdf=|usr=}}
| + | |
| − | {{tp|p=32134861|t=2020. The outbreak of COVID-19: An overview |pdf=|usr=}}
| + | |
| − | {{tp|p=32360509|t=ä. What evidence-based medicine researchers can do to help clinicians fighting COVID-2019?|pdf=|usr=}}
| + | |
| − | {{tp|p=32330521|t=ä. COVID-19 research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine |pdf=|usr=}}
| + | |
| − | {{tp|p=32325222|t=ä. Reply to letter to the editor ?Lessons from COVID-19 to Future Evidence Synthesis Efforts: First Living Search Strategy and Out of Date Scientific Publishing and Indexing Industry |pdf=|usr=}}
| + | |
| − | {{tp|p=32330122|t=2020. Panic prescribing has become omnipresent during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32244415|t=2020. People with Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health Literacy |pdf=|usr=}}
| + | |
| − | {{tp|p=18305135|t=2008. RNase-Resistant Virus-Like Particles Containing Long Chimeric RNA Sequences Produced by Two-Plasmid Coexpression System? |pdf=|usr=}}
| + | |
| − | {{tp|p=32315817|t=2020. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32303741|t=ä. Will COVID-19 Infection be Less Severe in Ulcerative Colitis Than in Crohn?s Patients, Due to a Lower Rate of Smokers?|pdf=|usr=}}
| + | |
| − | {{tp|p=32232431|t=2020. We are here for you and ready to hear from you |pdf=|usr=}}
| + | |
| − | {{tp|p=32209276|t=2020. Putting resiliency of a health system to the test: COVID-19 in Taiwan |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| + | |
| − | *[biomol.com assays cytokines general spectrum]
| + | |
| − | *[labospace.com custom single probe assay 400 possible cytokines and so on]
| + | |
| − | *
| + | |
| − | TAO technical wear masken die recht rational aussehen
| + | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
